Surgery
RSSArticles
-
Machine Learning Models Predict Recurrence, Complications Associated with Hernia Repair
Tool could prevent readmissions and repeat procedures while saving millions of dollars.
-
CABG Wins Again for Multivessel Disease
Fractional flow reserve-guided percutaneous coronary intervention failed to meet noninferiority guidelines vs. coronary artery bypass grafting.
-
Interatrial Shunt Device for Heart Failure Disappoints
Placement of an interatrial shunt device in patients with heart failure with preserved or mildly reduced ejection fraction did not lower the rate of heart failure events or improve health status.
-
Recommendations Target Making Improvements in U.S. Organ Transplant System
The authors aimed for equity, transparency, and efficiency.
-
Quality Improvement Initiative Leads to Significant Opioid Prescribing Reductions
Providers helped pediatric patients manage pain well after appendectomy.
-
CABG Wins Again for Multivessel Disease
In this contemporary trial of revascularization for multivessel disease, fractional flow reserve-guided percutaneous coronary intervention failed to meet noninferiority guidelines vs. coronary artery bypass grafting.
-
Orthopedic Surgeons Say ‘Open-Label’ Placebos Are Ethical, Yet Few Use Them
-
Post-TAVR Patients with Atrial Fibrillation Bleed Less on Vitamin K Antagonists vs. Edoxaban
In this randomized trial of post-transcatheter aortic valve replacement patients with atrial fibrillation, edoxaban was noninferior to vitamin K antagonists with regard to a composite of adverse endpoints, but was associated with a higher rate of major bleeding.
-
Informed Consent Challenges with High-Risk Surgery
There appears to be room for improvement when it comes to surgeons talking with patients about shared decision-making and providing specifics about quality of life after procedures.
-
Earlier Coronary Artery Bypass Grafting After Ticagrelor Discontinuation Is Safe
In a trial that included acute coronary syndrome patients treated with ticagrelor, undergoing coronary bypass surgery within two to three days was noninferior to the guideline-recommended five to seven days regarding severe bleeding.